To cite this paper use one of the standards below:
The aims of the present study are the development of Antiviral Medicinal Plants Natural Products Database (avMpNp DB) and the evaluation of the enzymatic inhibition of SARS-CoV-2 Mpro and PLpro in vitro of promising phenolics identified by this DB. The IC50 obtained for caffeic and gallic acid against SARS-CoV-2 Mpro was very promising, with values of 15.795 ± 0.155 μM and 6.308 ± 0.296 μM, respectively.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper